<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004101A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004101</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14013666</doc-number><date>20130829</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>D</subclass><main-group>417</main-group><subgroup>04</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>427</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>A</section><class>61</class><subclass>K</subclass><main-group>45</main-group><subgroup>06</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>D</subclass><main-group>417</main-group><subgroup>04</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc><further-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>45</main-group><subgroup>06</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>A</section><class>61</class><subclass>K</subclass><main-group>31</main-group><subgroup>427</subgroup><symbol-position>L</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></further-cpc></classifications-cpc><classification-national><country>US</country><main-classification>4241301</main-classification><further-classification>435375</further-classification><further-classification>514365</further-classification><further-classification>514249</further-classification></classification-national><invention-title id="d0e43">SMAC PEPTIDOMETICS USEFUL AS IAP INHIBITORS</invention-title><us-related-documents><continuation><relation><parent-doc><document-id><country>US</country><doc-number>12376057</doc-number><date>20101026</date></document-id><parent-grant-document><document-id><country>US</country><doc-number>8552003</doc-number></document-id></parent-grant-document><parent-pct-document><document-id><country>WO</country><doc-number>PCT/US07/74790</doc-number><date>20070731</date></document-id></parent-pct-document></parent-doc><child-doc><document-id><country>US</country><doc-number>14013666</doc-number></document-id></child-doc></relation></continuation><us-provisional-application><document-id><country>US</country><doc-number>60835000</doc-number><date>20060802</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only"><addressbook><last-name>Chen</last-name><first-name>Zhuoliang</first-name><address><city>Belmont</city><state>MA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="01" app-type="applicant" designation="us-only"><addressbook><last-name>Chen</last-name><first-name>Christine Hiu-Tung</first-name><address><city>Waltham</city><state>MA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="02" app-type="applicant" designation="us-only"><addressbook><last-name>Charest</last-name><first-name>Mark G.</first-name><address><city>Cambridge</city><state>MA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="03" app-type="applicant" designation="us-only"><addressbook><last-name>Dai</last-name><first-name>Miao</first-name><address><city>Shanghai</city><country>CN</country></address></addressbook><residence><country>CN</country></residence></us-applicant><us-applicant sequence="04" app-type="applicant" designation="us-only"><addressbook><last-name>He</last-name><first-name>Feng</first-name><address><city>Shanghai</city><country>CN</country></address></addressbook><residence><country>CN</country></residence></us-applicant><us-applicant sequence="05" app-type="applicant" designation="us-only"><addressbook><last-name>Huangshu</last-name><first-name>Lei</first-name><address><city>Durham</city><state>NC</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="06" app-type="applicant" designation="us-only"><addressbook><last-name>Pham</last-name><first-name>Ly Luu</first-name><address><city>Arlington</city><state>MA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="07" app-type="applicant" designation="us-only"><addressbook><last-name>Sharma</last-name><first-name>Sushil Kumar</first-name><address><city>West Orange</city><state>NJ</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="08" app-type="applicant" designation="us-only"><addressbook><last-name>Straub</last-name><first-name>Christopher Sean</first-name><address><city>Stow</city><state>MA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="09" app-type="applicant" designation="us-only"><addressbook><last-name>Wang</last-name><first-name>Run-Ming David</first-name><address><city>Cambridge</city><state>MA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="10" app-type="applicant" designation="us-only"><addressbook><last-name>Yang</last-name><first-name>Fan</first-name><address><city>West Roxbury</city><state>MA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant><us-applicant sequence="11" app-type="applicant" designation="us-only"><addressbook><last-name>Zawel</last-name><first-name>Leigh</first-name><address><city>Cambridge</city><state>MA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Chen</last-name><first-name>Zhuoliang</first-name><address><city>Belmont</city><state>MA</state><country>US</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Chen</last-name><first-name>Christine Hiu-Tung</first-name><address><city>Waltham</city><state>MA</state><country>US</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Charest</last-name><first-name>Mark G.</first-name><address><city>Cambridge</city><state>MA</state><country>US</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Dai</last-name><first-name>Miao</first-name><address><city>Shanghai</city><country>CN</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>He</last-name><first-name>Feng</first-name><address><city>Shanghai</city><country>CN</country></address></addressbook></inventor><inventor sequence="05" designation="us-only"><addressbook><last-name>Huangshu</last-name><first-name>Lei</first-name><address><city>Durham</city><state>NC</state><country>US</country></address></addressbook></inventor><inventor sequence="06" designation="us-only"><addressbook><last-name>Pham</last-name><first-name>Ly Luu</first-name><address><city>Arlington</city><state>MA</state><country>US</country></address></addressbook></inventor><inventor sequence="07" designation="us-only"><addressbook><last-name>Sharma</last-name><first-name>Sushil Kumar</first-name><address><city>West Orange</city><state>NJ</state><country>US</country></address></addressbook></inventor><inventor sequence="08" designation="us-only"><addressbook><last-name>Straub</last-name><first-name>Christopher Sean</first-name><address><city>Stow</city><state>MA</state><country>US</country></address></addressbook></inventor><inventor sequence="09" designation="us-only"><addressbook><last-name>Wang</last-name><first-name>Run-Ming David</first-name><address><city>Cambridge</city><state>MA</state><country>US</country></address></addressbook></inventor><inventor sequence="10" designation="us-only"><addressbook><last-name>Yang</last-name><first-name>Fan</first-name><address><city>West Roxbury</city><state>MA</state><country>US</country></address></addressbook></inventor><inventor sequence="11" designation="us-only"><addressbook><last-name>Zawel</last-name><first-name>Leigh</first-name><address><city>Cambridge</city><state>MA</state><country>US</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>NOVARTIS AG</orgname><role>03</role><address><city>Basel</city><country>CH</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">The present invention is directed to a compound of the formula:</p><p id="p-0002" num="0000"><chemistry id="CHEM-US-00001" num="00001"><img id="EMI-C00001" he="21.42mm" wi="65.62mm" file="US20140004101A1-20140102-C00001.TIF" alt="embedded image" img-content="chem" img-format="tif"/></chemistry></p><p id="p-0003" num="0000">or pharmaceutically acceptable salts thereof and use of such compounds for treating proliferative diseases such as cancer, in mammals.</p></abstract></us-patent-application>